Novasep Launches Next-Generation Biochromatography Equipment

News
Article

BioSC Lab is the first in a line of next-generation chromatography equipment for protein purification in batch and continuous modes.

Novasep, a supplier of manufacturing solutions for the life science industry, has launched BioSC Lab, the next-generation low-pressure chromatography equipment for the biopharmaceutical industry. Scientists will be able to purify a few grams of proteins per day either in continuous, batch, or even parallel batch modes with BioSC Lab.

According to Novasep, the simulation software BioSC Predict frees the process developer to set the most efficient mode and parameters to purify biomolecules such as monoclonal antibodies (mAbs), blood factors, and other proteins.

“Scientists are now asking for solutions to turn their traditional batch chromatography processes into continuous ones as early as the R&D stage,” said Jean-Luc Beulay, global product development director of Novasep’s Biopharma Business Unit, in a press statement. BioSC Lab has been designed to support this switch.  

“BioSC Lab has all those features state-of-the-art chromatography equipment must have in terms of reliability and efficiency. What makes it unique is its flexibility in process operating modes. It is specifically designed to quickly provide the operator with the best operating parameters for purifying and converting a batch biochromatography method into a continuous, optimized one.”

BioSC Lab is the first in a line of next-generation chromatography equipment that Novasep will introduce to the market over the next few years.

Source: Novasep

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content